Events

5th Antigen-Specific Immune Tolerance Drug Development Summit, virtual meeting

26-27 Januari 2021

Mangold Insight’s Investor Breakfast

29 September 2021

Aktiedagen Stockholm, virtual meeting

7 September 2021

MDA Insights in Research Investor Summit, virtual meeting

29-30 April 2021

4th Antigen-Specific Immune Tolerance Drug Development Summit, virtual meeting

26-28 January 2021

BioStock Live, Lund

8 September 2020

Stora Aktiedagen, Göteborg

4 November 2019

Sedermeradagen, Göteborg

4 October 2019

Småbolagsjakten Live, Stockholm

25 September 2019

Aktiekvällen, Göteborg

11 September 2019

World Orphan Drug Congress USA, Washington DC

10-12 April 2019

2nd Antigen-Specific Immune Tolerance Drug Development Summit, Boston

26-28 March 2019

Redeye Investor After Work, Göteborg

21 February 2019

1st Antigen-Specific Immune Tolerance Drug Development Europe, London

24-26 April 2018

BIO-Europe 2018 Partnering Conference, Copenhagen

5-7 November 2018

1st Antigen-Specific Immune Tolerance Drug Development Summit, Boston

24-26 April 2018

Aktiespararna Stockholm – Aktiekväll

19 February 2018

Connect2Capital Göteborg

7 February 2018

Aktiespararna Lerum – Årsmöte och Aktiekväll

25 January 2018

The business angel network IDA’s training day for members

2 June 2016
Charlotte Fribert, CEO, and Elisabet Litsmark, Chairman of the Board, will present Toleranzia and reasons why the company chose to be listed on AktieTorget at the business angel network IDA’s training day for members. IDA is a business angel network conducted within the framework of Connect West and investing in small entrepreneurial companies. The network has been around for about seven years and consists of some 30 women, several of whom have chosen to invest in Toleranzia.

Sedermeradagen Göteborg

1 June 2016
Charlotte Fribert, CEO, will present Toleranzia at Sedermeradagen Göteborg, taking place June 1 at Clarion Hotel Post in Gothenburg. Sedermeradagen Göteborg is arranged by Sedermera Fondkommission and is an investment day providing the opportunity to meet interesting companies within the micro- and small-cap segments.

World Orphan Drug Congress USA 2016

21 April 2016
Martina Verolin, Program Director, will present Toleranzia in the Pitch & Partner session at the World Orphan Drug Congress USA 2016, taking place at Washington Hilton, Washington, DC, USA, from 8 AM to 5 PM.

BIO-Europe Spring 2016

4-6 April 2016
Elisabet Litsmark Nordenstam, Chairman of the Board, will represent Toleranzia at the BIO-Europe Spring 2016 partnering conference, taking place at Kistamässan Convention Center in Kista (near Stockholm), Sweden.

GU Ventures’ 20th Anniversary Celebration

24 November 2015
The event will take place at the University of Gothenburg’s “Main Building” in Vasaparken, Gothenburg, Sweden, from noon to 3 p.m. Björn Löwenadler, CEO, and Charlotte Fribert, COO, will represent Toleranzia at the event. Registration is required no later than 17 November to ewa.ekman@ventures.gu.se.